Featured Research

from universities, journals, and other organizations

Hypothermia shown to improve survival and outcomes following out-of-hospital cardiac arrest

Date:
April 6, 2011
Source:
Mary Ann Liebert, Inc./Genetic Engineering News
Summary:
The successful use and evaluation of therapeutic hypothermia to improve survival and reduce the risk of neurological consequences following an out-of-hospital heart attack are explored in a new article.

The successful use and evaluation of therapeutic hypothermia to improve survival and reduce the risk of neurological consequences following an out-of-hospital heart attack are explored in the premier issue of Therapeutic Hypothermia and Temperature Management, a new quarterly peer-reviewed journal published by Mary Ann Liebert, Inc. This groundbreaking new publication covers all aspects of hypothermia and temperature considerations relevant to this exciting field, including its application in cardiac arrest, spinal cord and traumatic brain injury, stroke, myocardial ischemia, neurogenic fever, emergency medicine, ICU management, anesthesiology, pediatrics, and much more.

According to the review article on "The Use of Hypothermia Therapy in Cardiac Arrest Survivors," therapeutic hypothermia appears to reduce the risk of brain injury in the approximately 400,000 people who suffer an out-of-hospital cardiac arrest in the U.S. each year. The authors, Sanjeev Nair and Justin Lundbye, Hartford Hospital (CT) and University of Connecticut School of Medicine, in Farmington, discuss when therapeutic hypothermia should and should not be used, various methods of reducing body temperature, and the different phases of hypothermia.

The Journal is under the editorial leadership of Editor-in-Chief W. Dalton Dietrich, PhD, Kinetic Concepts Distinguished Chair in Neurosurgery, Professor of Neurological Surgery, Neurology and Cell Biology and Anatomy, University of Miami Leonard M. Miller School of Medicine; European Editor Hans Friberg, MD, PhD, Lund University, Lund, Sweden; Australasian Editor Stephen Bernard, MD, The Alfred Hospital, Victoria, Australia; and a distinguished multidisciplinary editorial board.

Therapeutic Hypothermia and Temperature Management provides a strong multidisciplinary forum to foster greater understanding and awareness of this new emerging therapy and its clinical applications. The Journal spans basic research through clinical application and engages all members of the therapeutic hypothermia clinical team, including physicians, nurses, and first responders. Novel findings from translational preclinical investigations as well as clinical studies and trials are featured in original articles, state-of-the-art review articles, provocative roundtable discussions, clinical protocols, and best practices. Therapeutic Hypothermia and Temperature Management will be the journal of record, published in print and online with open access options.

Other topically related articles in the premier issue include: "Use of Therapeutic Hypothermia in Postcardiac Arrest Patients by Emergency Departments," which reports on a survey of emergency physicians in the U.S. to assess their use of therapeutic hypothermia in patients who suffer a heart attack and whose circulation is restored following ventricular fibrillation, and "Should Advanced Age Be A Limiting Factor in Providing Therapeutic Hypothermia to Cardiac Arrest Survivors? A Single-Center Observational Study," which reviews the outcomes of 113 unconscious out-of-hospital cardiac arrest survivors from 2002-2008 to determine whether older patients benefit from body temperature reducing therapy.

The inaugural issue of the Journal also includes a novel article describing the first study to explore the use of hypothermia in penetrating ballistic injury, entitled "Neuroprotection of Selective Brain Cooling after Penetrating Ballistic-like Brain Injury in Rats," and a case report on "Hypothermia and Protection from Acetaminophen-induced Liver Injury." Also featured is a provocative roundtable discussion on the "Future of Rewarming in Therapeutic Hypothermia for Traumatic Brain Injury: A Personalized Plan," and "The Arctic Challenge: Clinical Q&A," a regular feature of the Journal targeting first responders and the clinical care team in the emergency room and the ICU that will focus on translating therapeutic temperature management from theory to practice.

"The use of therapeutic hypothermia in the treatment of severely injured patients is now emerging as an acceptable and effective therapy," says Editor-in-Chief W. Dalton Dietrich. "Therapeutic Hypothermia and Temperature Management emerges at a time when increased communication in the field is urgently needed."


Story Source:

The above story is based on materials provided by Mary Ann Liebert, Inc./Genetic Engineering News. Note: Materials may be edited for content and length.


Cite This Page:

Mary Ann Liebert, Inc./Genetic Engineering News. "Hypothermia shown to improve survival and outcomes following out-of-hospital cardiac arrest." ScienceDaily. ScienceDaily, 6 April 2011. <www.sciencedaily.com/releases/2011/04/110406123015.htm>.
Mary Ann Liebert, Inc./Genetic Engineering News. (2011, April 6). Hypothermia shown to improve survival and outcomes following out-of-hospital cardiac arrest. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2011/04/110406123015.htm
Mary Ann Liebert, Inc./Genetic Engineering News. "Hypothermia shown to improve survival and outcomes following out-of-hospital cardiac arrest." ScienceDaily. www.sciencedaily.com/releases/2011/04/110406123015.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins